Matches in Wikidata for { <http://www.wikidata.org/entity/Q91609793> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91609793 description "article scientifique publié en 2019" @default.
- Q91609793 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91609793 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91609793 description "scientific article published on 15 April 2019" @default.
- Q91609793 description "wetenschappelijk artikel" @default.
- Q91609793 description "наукова стаття, опублікована 15 квітня 2019" @default.
- Q91609793 description "գիտական հոդված հրատարակված 2019 թվականի ապրիլի 15-ին" @default.
- Q91609793 name "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 name "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 type Item @default.
- Q91609793 label "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 label "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 prefLabel "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 prefLabel "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 P1433 Q91609793-05AF675D-8CE9-469F-9465-D011DE4E8948 @default.
- Q91609793 P1476 Q91609793-8A61F3C3-9D9E-4BF5-BD42-1536BFC00BD4 @default.
- Q91609793 P2093 Q91609793-253C9B4B-8B91-41EA-B743-354093926A26 @default.
- Q91609793 P2093 Q91609793-349FD150-3BE2-4740-B34F-6E45E0215E50 @default.
- Q91609793 P2093 Q91609793-72B8D048-F59D-4EB8-9DEF-C391C5A16CF0 @default.
- Q91609793 P2093 Q91609793-F5C4ED03-55B9-48A5-84B8-21E14516FC82 @default.
- Q91609793 P304 Q91609793-B989216C-78D8-46E1-BC46-7255DBE5DED4 @default.
- Q91609793 P31 Q91609793-104615ED-E997-4446-9F56-C47EC03D2F74 @default.
- Q91609793 P356 Q91609793-4356D346-F48D-4591-B811-422B12CA15FD @default.
- Q91609793 P478 Q91609793-25A37186-5DDE-4A9B-A3BE-1BBFC314E245 @default.
- Q91609793 P577 Q91609793-5322EB8D-9AEB-4429-BF66-DFF3162D10B0 @default.
- Q91609793 P698 Q91609793-1DD7B9FA-62AE-485A-8625-C1AC0C2A5C63 @default.
- Q91609793 P921 Q91609793-8D6A1640-EB44-4C55-AB2D-32FA0E322564 @default.
- Q91609793 P921 Q91609793-D4F6F42E-BEDB-4202-ACCC-866B4ECF425A @default.
- Q91609793 P356 J.EPLEPSYRES.2019.03.011 @default.
- Q91609793 P698 31035244 @default.
- Q91609793 P1433 Q15746405 @default.
- Q91609793 P1476 "Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model" @default.
- Q91609793 P2093 "Katsutoshi Ido" @default.
- Q91609793 P2093 "Makoto Ohgoh" @default.
- Q91609793 P2093 "Takahisa Hanada" @default.
- Q91609793 P2093 "Ting Wu" @default.
- Q91609793 P304 "42-49" @default.
- Q91609793 P31 Q13442814 @default.
- Q91609793 P356 "10.1016/J.EPLEPSYRES.2019.03.011" @default.
- Q91609793 P478 "154" @default.
- Q91609793 P577 "2019-04-15T00:00:00Z" @default.
- Q91609793 P698 "31035244" @default.
- Q91609793 P921 Q6279182 @default.
- Q91609793 P921 Q6410625 @default.